340B Compliance: HRSA Outlines Use Of Extra Funding For 2014
This article was originally published in The Pink Sheet Daily
Executive Summary
The $6 million Congress appropriated to the Health Resources and Services Administration to boost its oversight of compliance with 340B drug discount program rules is being used to analyze information from recent program integrity efforts, conduct additional audits and install IT systems that will allow it to track compliance by health care providers and drug manufacturers.